Oncology & Cancer

PSA levels no different with exposure to antidiabetes meds

(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to ...

Oncology & Cancer

Expert panel suggests PSA test may benefit some men

(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.

Oncology & Cancer

High-intensity interval training beneficial in prostate cancer

(HealthDay)—For men with low-risk to favorable intermediate-risk prostate cancer undergoing active surveillance, high-intensity interval training (HIIT) increases peak oxygen consumption and is associated with reduced prostate-specific ...

Oncology & Cancer

Study: New prostate cancer test could avoid unnecessary biopsies

A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation ...

Oncology & Cancer

Doctors differ on prostate screening

Prostate screening tests detect prostate cancer early, but questions about whether the tests do more harm than good have made them one of the most hotly debated areas of medicine.

page 19 from 33